Last reviewed · How we verify

NCT04518579: tumorimmunity

Epidural-inhalational Versus Epidural-intravenous Anaesthesia on Anti-tumor Immunity in Patients With Cancer Colon

Completed NA Last updated 21 August 2020
What this trial tests

NA trial testing thoracic epidural in Immunity Factors in Cancer Colon Patients in 48 participants. Completed in 1 August 2020.

Timeline
15 April 2018
Primary endpoint
1 June 2020
1 August 2020

Quick facts

Lead sponsorSouth Egypt Cancer Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment48
Start date15 April 2018
Primary completion1 June 2020
Estimated completion1 August 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

South Egypt Cancer Institute

Who can join

Adults 20 to 70, any sex, with Immunity Factors in Cancer Colon Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Surgery is the primary treatment for colon cancer. However, the rate of recurrence or metastasis in colon cancer can be as high as 30%, even in stages 1 and 2 . Most colon cancer-related deaths are caused by metastatic disease . Many patients with colon cancer harbour micrometastases and disseminated tumour cells at the time of surgery . Whether the micrometastases develop into clinically significant metastases depends on the immune system's ability to eradicate them.The aim of the study is to declare the effect of epidural-intravenous based anesthetic technique on anti-tumor immunity and in comparison to epidural inhalational based anesthetic technique in patients undergoing open surgical resection of colon cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of thoracic epidural

Trials testing the same drug.

Other South Egypt Cancer Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04518579.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing